France extends medical cannabis trial to help patients find alternatives

December 21, 2024

French health authorities have extended a medical cannabis experiment until 31 July 2025, giving 1,800 patients more time to stop treatment or find alternatives.

Under the medical cannabis trial, rolled out in March 2021, patients suffering from serious pathologies were prescribed active cannabis-derived substances in the form of essential oils to be taken orally, or of cannabis flowers for vaping.

The experiement was due to end on 31 December 2024, but at a meeting on Thursday between patient associations and the health authorities, the Ministry of Health gave the green light for it to run for a further six months, FranceInfo reported.

The extension will be granted only “with a view to weaning patients off the drug or finding alternatives”, the resigning Health Minister, Geneviève Darrieussecq, wrote in the letter enabling the decision.

ADVERTISEMENT

Patients hopeful for France’s medical cannabis experiment

Cannabis is banned in France, even for medical purposes, but patients associations have long been lobbying to get it cleared for use to relieve chronic pain.

Medical cannabis is legal in 33 countries, with South American nations leading the way.

Read more on RFI English

Read also:
Patients hopeful for France’s medical cannabis experiment
Medicinal cannabis should be legalised in France, according to study
Court reverses French ban on sale of cannabis-derived CBD flowers and leaves

 

Search

RECENT PRESS RELEASES